Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI stethoscope vs. Doctor's ear: which finds more heart problems in kids?

NCT ID NCT06791109

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This large study in China compared how well primary care doctors detect congenital heart disease in children using a regular stethoscope versus an AI-assisted electronic stethoscope. Nearly 20,000 children aged 0-18 from schools and kindergartens were screened. The goal was to see if AI help reduces missed diagnoses and expands screening coverage.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-assisted heart sound analysis
What this could lead to
If successful, this could show that AI helps primary care doctors detect more heart defects in children during routine check-ups, potentially leading to earlier treatment.
What could go wrong
This is a completed trial, but results are not yet published. The AI may not perform better than specialists, and the findings may not apply outside of China's school screening system.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

19,697 people

The number who actually took part.

Started

Sep 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (Schools): * The school is of the type: kindergarten, primary school, junior high school, or senior high school. * The school has medical screening facilities and conditions that can support AI-assisted screening. * The area where the school is located has at least one primary healthcare institution willing to participate in this trial. * The school's management and teaching staff are willing to participate in the study and can cooperate to complete the related screening and data collection work. Exclusion Criteria (Schools): * More than half of the students in the school refuse to participate in the trial. * Schools that are unable to complete the study due to severe limitations in geographical location and transportation conditions. * Schools lacking medical screening facilities and conditions necessary for the implementation of screening. * Areas where there are no primary healthcare institutions willing to participate in this trial. * Schools whose management and teaching staff refuse to participate in the study or are unable to cooperate in completing the related screening and data collection work. Inclusion Criteria (Individuals): * Children aged between 0 and 18 years, regardless of gender. * Children who agree to undergo echocardiography to determine the presence of congenital heart disease. * Individuals who voluntarily participate in this study and sign the informed consent form. Exclusion Criteria (Individuals): * Individuals over the age of 18. * Children who are unable to complete echocardiography or do not cooperate with auscultation. * Participants who are unable to provide informed consent or are unwilling to comply with the study requirements to provide medical data for further analysis and research. * Participants who have received interventional or surgical treatment for CHD.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Artificial intelligence (AI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Qinghai Provincial Women and Children's Hospital

    Xining, Qinghai, 810007, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.